Cargando…
Multicenter Study of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Strains in China
Colistin has been considered a last-line option for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). Heterogeneous resistance to colistin leads to unexplained clinical colistin treatment failure for CRKP. Our study aimed to investigate the extent of colistin h...
Autores principales: | Weng, Yuesong, Wang, Tao, Huang, Bin, Yu, Hua, Jia, Wei, Shan, Bin, Qu, Fen, Tang, Yiwei, Chen, Liang, Du, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434274/ https://www.ncbi.nlm.nih.gov/pubmed/37428093 http://dx.doi.org/10.1128/spectrum.02218-22 |
Ejemplares similares
-
Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection
por: Band, Victor I., et al.
Publicado: (2018) -
Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant Enterobacterales in the United States
por: Band, Victor I., et al.
Publicado: (2021) -
Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Zhang, Feiyang, et al.
Publicado: (2021) -
Heteroresistance Is Associated With in vitro Regrowth During Colistin Treatment in Carbapenem-Resistant Klebsiella pneumoniae
por: Wang, Yifan, et al.
Publicado: (2022) -
Heteroresistance to Colistin in Clinical Isolates of Klebsiella pneumoniae Producing OXA-48
por: Sánchez-León, Irene, et al.
Publicado: (2023)